Browse by UCL people
Group by: Type | Date
Jump to: Article | Working / discussion paper
Number of items: 25.
Article
Ahmed, F;
Maclean, RH;
Nihtyanova, SI;
Ong, VH;
Murray, CD;
Denton, CP;
(2022)
Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis.
Rheumatology
, 61
(2)
pp. 781-786.
10.1093/rheumatology/keab395.
|
|
Brooks, AJ;
Smith, PJ;
Cohen, R;
Collins, P;
Douds, A;
Forbes, V;
Gaya, DR;
... Lindsay, JO; + view all
(2017)
UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care.
Gut
, 66
(6)
pp. 988-1000.
10.1136/gutjnl-2016-313000.
|
 |
|
Davrandi, M;
Harris, S;
Smith, PJ;
Murray, CD;
Lowe, DM;
(2022)
The Relationship Between Mucosal Microbiota, Colitis, and Systemic Inflammation in Chronic Granulomatous Disorder.
Journal of Clinical Immunology
, 42
pp. 312-324.
10.1007/s10875-021-01165-6.
|
|
Denton, CP;
Murray, C;
(2019)
Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis.
Arthritis Research & Therapy
, 21
, Article 81. 10.1186/s13075-019-1872-4.
|
|
|
Goodman, AL;
Murray, CD;
Watkins, J;
Griffiths, PD;
Webster, DP;
(2015)
CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis.
Eur J Clin Microbiol Infect Dis
, 34
(1)
13 - 18.
10.1007/s10096-014-2212-x.
|
 |
|
Hughes, M;
Allanore, Y;
Baron, M;
Del Galdo, F;
Denton, CP;
Frech, T;
Furst, DE;
... Matucci-Cerinic, M; + view all
(2022)
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease.
The Lancet Rheumatology
, 4
(11)
e795-e803.
10.1016/S2665-9913(22)00183-7.
|
|
Johnson, SR;
Soowamber, ML;
Fransen, J;
Khanna, D;
Van den Hoogen, F;
Baron, M;
Matucci-Cerinic, M;
... Pope, JE; + view all
(2018)
There is a need for new systemic sclerosis subset criteria. A content analytic approach.
Scandinavian Journal of Rheumatology
, 47
(1)
pp. 62-70.
10.1080/03009742.2017.1299793.
|
|
|
Lin, Simeng;
Kennedy, Nicholas A;
Saifuddin, Aamir;
Sandoval, Diana Munoz;
Reynolds, Catherine J;
Seoane, Rocio Castro;
Kottoor, Sherine H;
... Ahmad, Tariq; + view all
(2022)
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Nature Communications
, 13
, Article 1379. 10.1038/s41467-022-28517-z.
|
|
Lovat, L;
Murray, C;
Haidry, R;
(2019)
Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia.
United European Gastroenterology Journal
, 7
(2)
pp. 217-224.
10.1177/2050640618814659.
|
|
Lowe, DM;
Smith, PJ;
Moreira, F;
Workman, S;
Braggins, H;
Koukias, N;
Buckland, MS;
... Murray, CD; + view all
(2019)
Chronic Granulomatous Disorder-Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level.
Journal of Clinical Immunology
10.1007/s10875-019-00651-2.
(In press).
|
|
|
Magee, C;
Graham, D;
Leonard, C;
McMaster, J;
Davies, H;
Skotchko, M;
Lovat, L;
... Haidry, R; + view all
(2020)
The cost-effectiveness of radiofrequency ablation for treating patients with gastric antral vascular ectasia refractory to first line endoscopic therapy.
Current Medical Research and Opinion
10.1080/03007995.2020.1747997.
(In press).
|
|
|
Miles, A;
Bhatnagar, G;
Halligan, S;
Gupta, A;
Tolan, D;
Zealley, I;
Taylor, SA;
(2019)
Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn's disease: patient acceptability and perceived burden.
European Radiology
, 29
(3)
pp. 1083-1093.
10.1007/s00330-018-5661-2.
|
|
|
Murray, CDR;
Martin, NM;
Patterson, M;
Taylor, SA;
Ghatei, MA;
Kamm, MA;
Johnston, C;
... Emmanuel, AV; + view all
(2005)
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
GUT
, 54
(12)
pp. 1693-1698.
10.1136/gut.2005.069088.
|
|
|
Parisi, I;
O'Beirne, J;
Rossi, RE;
Tsochatzis, E;
Manousou, P;
Theocharidou, E;
Hamilton, M;
... Burroughs, AK; + view all
(2016)
Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.
European Journal of Gastroenterology & Hepatology
, 28
(7)
pp. 786-791.
10.1097/MEG.0000000000000624.
|
|
Raja, J;
Nihtyanova, SI;
Murray, CD;
Denton, CP;
Ong, VH;
(2016)
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis.
Rheumatology
, 55
(1)
pp. 115-119.
10.1093/rheumatology/kev318.
|
|
|
Saifuddin, Aamir;
Kent, Alexandra J;
Mehta, Shameer J;
Hicks, Lucy C;
Gonzalez, Haidee A;
Segal, Jonathan P;
Brookes, Matthew J;
... Sebastian, Shaji; + view all
(2022)
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Alimentary Pharmacology and Therapeutics
, 56
(10)
pp. 1460-1474.
10.1111/apt.17223.
|
|
Schiff, ER;
Frampton, M;
Ben-Yosef, N;
Avila, BE;
Semplici, F;
Pontikos, N;
Bloom, SL;
... Levine, AP; + view all
(2018)
Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.
Human Genetics
, 137
(9)
pp. 723-734.
10.1007/s00439-018-1927-7.
|
 |
|
Schiff, ER;
Frampton, M;
Semplici, F;
Bloom, SL;
McCartney, SA;
Vega, R;
Lovat, LB;
... Levine, AP; + view all
(2018)
A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
Digestive Diseases and Sciences
, 63
(11)
pp. 3049-3057.
10.1007/s10620-018-5219-9.
|
|
Sebastian, S;
Walker, GJ;
Kennedy, NA;
Conley, TE;
Patel, KV;
Subramanian, S;
Kent, AJ;
... PROTECT-ASUC Study Group; + view all
(2021)
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
The Lancet Gastroenterology & Hepatology
10.1016/S2468-1253(21)00016-9.
(In press).
|
|
Stankey, CT;
Bourges, C;
Haag, LM;
Turner-Stokes, T;
Piedade, AP;
Palmer-Jones, C;
Papa, I;
... Lee, JC; + view all
(2024)
A disease-associated gene desert directs macrophage inflammation through ETS2.
Nature
, 630
pp. 447-456.
10.1038/s41586-024-07501-1.
|
|
Taylor, S;
Mallett, S;
Bhatnagar, G;
Bloom, S;
Gupta, A;
Halligan, S;
Hamlin, J;
... Zealley, I; + view all
(2014)
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over.
BMC Gastroenterol
, 14
, Article 142. 10.1186/1471-230X-14-142.
|
|
|
Taylor, SA;
Mallett, S;
Bhatnagar, G;
Baldwin-Cleland, R;
Bloom, S;
Gupta, A;
Hamlin, PJ;
... METRIC study investigators; + view all
(2018)
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial.
Lancet Gastroenterology and Hepatology
, 3
(8)
pp. 548-558.
10.1016/S2468-1253(18)30161-4.
|
|
|
Taylor, SA;
Mallett, S;
Bhatnagar, G;
Morris, S;
Quinn, L;
Tomini, F;
Miles, A;
... Halligan, S; + view all
(2019)
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Health Technol Assess
, 23
(42)
pp. 1-161.
10.3310/hta23420.
|
|
Working / discussion paper
|
Lin, S;
Kennedy, N;
Saifuddin, A;
Sandoval, DM;
Reynolds, C;
Seoane, RC;
Kottoor, S;
... Contributors of the CLARITY IBD study, .; + view all
(2021)
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients.
Cold Spring Harbor Laboratory
|
|
|
Lin, Simeng;
Kennedy, Nicholas;
Saifuddin, Aamir;
Sandoval, Diana Muñoz;
Reynolds, Catherine;
Seoane, Rocio Castro;
Kottoor, Sherine;
... Ahmad, Tariq; + view all
(2021)
Covid-19 vaccine-induced antibodies are attenuated and decay rapidly in infliximab treated patients.
Research Square: Durham, NC, USA.
|
|
